Today: 1 July 2026
Browse Category

NASDAQ:RMD 10 January 2026

AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next

New York, January 9, 2026, 20:18 — Market closed AbbVie Inc. shares dropped 1.8% on Friday, closing at $220.08. The decline followed the drugmaker’s decision to lower its 2025 earnings forecast and a denial of reports suggesting it was in talks to acquire cancer-drug developer Revolution Medicines. Since 2023, AbbVie has spent over $20 billion on acquisitions, aiming to offset the impact from Humira’s patent expiration.
10 January 2026
···

Stock Market Today

  • US Futures Dip as Oil Drops, Investors Weigh Inflation Signals
    July 1, 2026, 5:49 AM EDT. US stock futures slipped early Wednesday, with E-mini S&P 500 and Micro E-mini Nasdaq-100 contracts both down as trading opened to mixed macro news. The Strategic Petroleum Reserve is now at its lowest since 1983 after a big release aimed at lowering fuel prices, temporarily easing inflation on consumers. Oil retreated, while eurozone inflation stuck close to the 2% mark, leaving questions about just how much cheaper energy will affect banks, utilities, and real estate stocks. Sandisk jumped almost 11% on a price target bump, Credo Technology climbed on new index inclusions, and Bloom Energy advanced with more funding. Traders watched for fresh inflation data, oil supply numbers, and China's manufacturing reports as they tried to gauge how stable markets are with rate hikes still in focus.
Go toTop